You'll get FREE Breaking News Alerts on new MS treatments as they are approved
PLUS: Plus...we will notify you when we produce videos like the one below that we filmed last year...with Dr. Timothy Vollmer to help you understand Tysabri's withdrawal from the market
Timothy L. Vollmer M.D. Program Director, BNI Neuroimmunology Program
Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"Join a trial at Barrow & receive all medication & study based procedures at
no charge!"
Stan Swartz, CEO, The MD Health Channel "WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!"
Simply click the "video" buttons below: .
"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean
"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson
"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore
"OUR TEAM IS WORKING ON A CURE FOR MS"
Runtime: 54 sec
Runtime: 54 sec
Susan N. Rhodes Multiple Sclerosis Research
Barrow Neurological Institute
"'The 2006 Barrow Neurological Institute at St. Joseph's Hospital MS "Walk on the Wild Side" raised more than $460,000 with 3,500 walkers! Click on the blue link above to view photos"
Chris Uithoven President
National Multiple Sclerosis Society
Arizona Chapter
"THE MS SOCIETY OFFERS MANY PROGRAMS TO HELP...EVERYTHING FROM PILATES & SUPPORT GROUPS TO HORSEBACK RIDING"
Jerry Turner Program Director
National Multiple Sclerosis Society
Arizona Chapter
Scientist May Have Found a Way to Reverse Myelin Damage in Those With MS
Dr. Vittorio Gallo, director at Center for Neuroscience Research at Children’s National Medical System, and fellow researchers were able to identify a molecule, Endothelin-1 (ET-1), as what inhibits the repair of myelin and believe they can find a way to ‘target’ this protein to stimulate the repairing of the sheathe.
Dr. Gallo and laboratory members directed their attention to and are currently moving on with the next step: “They are currently analyzing ET-receptor B knock-out mutants to determine which ET receptor subtype is involved in the biological effects observed.
Finding ways to repair the myelin that MS destroys is a fairly new path, in that it has been in only the last few years that findings have been coming out; scientists and researchers have taken in trying to stop the progression
Dr. Gallo said, “We demonstrate that ET-1 drastically reduces the rate of remyelination. This creates a new drug target in the treatment of MS [as] ET-1 is “potentially a therapeutic target to promote lesion repair in deymyelinated tissue.”
My Educational Video on MS and MS Trials
Post a Comment